Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Neoplasm Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00561522
What this trial is testing

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Who this might be right for
Hepatocellular CarcinomaNeoplasm Metastasis
Fudan University 290
Testing effectiveness (Phase 2)Study completedNCT00056030
What this trial is testing

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 73
Early research (Phase 1)Study completedNCT00327652
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

Who this might be right for
Neoplasm MetastasisLiver NeoplasmsCarcinoma
Anza Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00508001
What this trial is testing

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Genzyme, a Sanofi Company 67
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Early research (Phase 1)Study completedNCT03876574
What this trial is testing

Hepatic Artery Infusion Pump for NPC Liver Metastases

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLiver
Xiangya Hospital of Central South University 16
Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT04602026
What this trial is testing

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

Who this might be right for
Adult Liver CarcinomaGastric CarcinomaMalignant Solid Neoplasm+1 more
Ohio State University Comprehensive Cancer Center 66
Large-scale testing (Phase 3)Ended earlyNCT00268463
What this trial is testing

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 22
Large-scale testing (Phase 3)Study completedNCT00902343
What this trial is testing

Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center 149
Testing effectiveness (Phase 2)Study completedNCT04021043
What this trial is testing

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Carcinoma in the LiverMetastatic Carcinoma in the Lung+2 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Not applicableUnknownNCT03266042
What this trial is testing

Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Who this might be right for
Hepatic Malignant Neoplasm Primary Non-Resectable
Delcath Systems Inc. 200
Testing effectiveness (Phase 2)Study completedNCT00103142
What this trial is testing

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Michael Morse, MD 74
Early research (Phase 1)WithdrawnNCT03217253
What this trial is testing

Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction

Who this might be right for
Ann Arbor Stage III B-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV B-Cell Non-Hodgkin LymphomaMetastatic Malignant Solid Neoplasm+8 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01273493
What this trial is testing

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Who this might be right for
Neoplasm MetastasesHepatic Insufficiency
Janssen Research & Development, LLC 15
Testing effectiveness (Phase 2)Ended earlyNCT04785287
What this trial is testing

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Who this might be right for
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Next Page